Research and Development

Showing 15 posts of 9573 posts found.

EMA eyes stem cell research breakthrough

May 18, 2010 Research and Development EMA, Stem cells, stem cell

European regulators are readying themselves to deal with the region’s first marketing authorisation application for a stem cell product. The …

Pfizer signs ground-breaking academic research deal

May 18, 2010 Research and Development Pfizer, US, academia, clinical research

Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …

Bayer opens US ‘science hub’

May 18, 2010 Research and Development Bayer, US, acdemia, clinical research

Bayer Schering Pharma has expanded its global research network, opening a new Innovation Center in San Francisco. The US centre …

Merck’s Brinavess performs in phase III

May 18, 2010 Research and Development Brinavess, Merck & Co, atrial fibrilation

Merck & Co’s heart disorder drug Brinavess has proved superior to rival amiodarone in reducing rates of atrial fibrillation in …

New global ‘polypill’ trials start

May 17, 2010 Research and Development Dr Reddy, hypertension, polypill, statin

New trials of a daily polypill – combining aspirin, a statin and two blood pressure lowering medicines – are underway …

Takeda plans cuts, eyes mergers

May 17, 2010 Research and Development, Sales and Marketing Takeda, job cuts

Takeda is planning to cut its workforce by 10% through a series of cuts that will predominantly be made to …
OSI Pharmaceuticals

Astellas set to acquire OSI Pharmaceuticals for $4bn

May 17, 2010 Research and Development, Sales and Marketing Astellas, M&A, MA, OSI

After four months and several failed bids Astellas Pharma has signed a definitive merger agreement with US biotech firm OSI …
Europe map

EMA readies paediatric trials network

May 14, 2010 Research and Development EMA, EMEA, paediatric, paediatric trials

The European Medicines Agency is about to press the start button on its long-planned network for clinical studies in children. …

Pfizer adds another product to its PAH franchise

May 14, 2010 Research and Development Ergonex, PAH, Pfizer, Thelin, revatio, terguride, viagra

Pfizer has signed an agreement to acquire terguride, a drug for pulmonary arterial hypertension (PAH) currently in phase II testing, …

Contract research news in brief

May 14, 2010 Research and Development CRO, Clinipace, Covance, Encorium, IR Pharma, Imperial College, PPD, Parexel

Developments in the contract research sector this week include the opening of new offices for Parexel and PPD, the spin-out …

Cedra appoints Anthony Busa

May 14, 2010 Research and Development CRO, Cedra, appointment, research and development

Phase I clinical trial specialist Cedra Corp division has appointed Anthony Busa as its new permanent chief executive, replacing acting …

WuXi posts buoyant increases in revenue and profit

May 13, 2010 Research and Development CRO, Charles River, Charles River Laboratories, WuXi

China’s WuXi PharmaTech has given would-be purchaser Charles River Laboratories a lift after posting buoyant increases in both revenues and …

Phillipe Lutz joins Telormedix

May 13, 2010 Research and Development appointment, research and development, telormedix

Swiss clinical stage biopharmaceutical company Telormedix has appointed Phillipe Lutz chief financial officer. He joins the company from Synosia Therapeutics, …

Kendle operating income slumps

May 13, 2010 Research and Development CRO, Kendle

US contract research organisation Kendle posted a 17% drop in revenues in the first quarter of 2010 to $90 million, …

Emerging markets key for Merck’s long-term performance

May 13, 2010 Research and Development, Sales and Marketing Merck & Co, em

Merck & Co has highlighted emerging markets such as China and Latin America as a major driver for its success …
The Gateway to Local Adoption Series

Latest content